TPD52 and breast carcinoma: Breast cancer cells may be inhibited from autophagy, proliferation, and migration by HMGB1 [17]; in addition, several research studies have discovered that miR-107 controls PTX sensitivity via Wnt/-catenin signaling pathway, which targets TPD52 [18–20], [17, 18, 18–20].